Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding

Journal of Pharmaceutical Sciences

Volumn 92, Issue 5, 2003, Pages 967-974

  Banker, Michael J ^a   Clark, Tracey H ^a   Williams, John A ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Equilibrium dialysis; High throughput screening; Protein binding; Volume shifts

Indexed keywords

ARTICLE; DEVICE; DIALYSIS MEMBRANE; EQUILIBRIUM DIALYSIS; PLASMA PROTEIN BINDING; ROBOTICS; TEMPERATURE;

EID: 0037407697     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10332     Document Type: Article

References (36)

1. Greenblatt DJ, Sellers EM, Koch-Weser J. 1982. Importance of protein binding for the interpretation of serum or plasma drug concentrations. J Clin Pharmacol 22:259-263.
2. Kwong TC. 1985. Free drug measurements: Methodology and clinical significance. Clin Chim Acta 151:193-216.
3. Herve F, Urien S, Albengres E, Duche J. 1994. Drug binding in plasma. Clin Pharmacokinet 25(1): 44-58.
4. Schuhmacher J, Buhner K, Witt-laido A. 2000. Determination of the free fraction and relative free fraction of drugs strongly bound to plasma proteins. J Pharm Sci 89:1008-1021.
5. Swensson CK, Woodruff MN, Baxter JG, Lalka D. 1986. Free drug concentration monitoring in clinical practice: Rational and current status. Clin Pharmacokinet 11:450-469.
6. Swift CG, Ewin JM, Clark P, Stevenson IH. 1985. Responsiveness to oral diazepam in the elderly: Relationship to total and free plasma concentrations. Br J Clin Pharmacol 20(2):111-118.
7. Pacific GM, Viani A. 1992. Methods of determining plasma and tissue binding of drugs. Clin Pharmacokinet 23:449-468.
8. Sebille B. 1990. Methods of drug protein binding determinations. Fundam Clin Pharmacol 4(suppl 2): 151-161.
9. Huang J. 1983. Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis. J Pharm Sci 72:1358-1359.
10. Lima J, MacKichan JJ, Libertin N, Sabino J. 1983. Influence of volume shifts on drug binding during equilibrium dialysis: correction and attenuation. J Pharmacokinet Biopharm 11:483-498.
11. Boudinot FD, Jusko WJ. 1984. Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. J Pharm Sci 73:774-780.
12. Kristensen CB, Gram LF. 1982. Equilibrium dialysis for determination of protein binding of imipramine - evaluation of a method. Acta Pharmacol Toxicol 50:129-135.
13. Dayton PG, Stiller RL, Cook DR, Perel JM. 1983. The binding of ketamine to plasma proteins: Emphasis on human plasma. Eur J Clin Pharmacol 24:825-830.
14. Ponganis KV, Stanski DR. 1985. Factors affecting the measurement of lidocaine protein binding by equilibrium dialysis in human serum. J Pharm Sci 74(1):57-60.
15. Oldenburg K. 1998. Current and future trends in high throughput screening for drug discovery. Ann Rep Med Chem 32:291-301.
16. Krebs R. 1999. Novel technology to improve pharmaceutical productivity. Curr Opin Drug Discovery Devel 2:238-242.
17. Smith DA, Van Der Waterbeemd H. 1999. Pharmacokinetics and metabolism in early drug discovery. Curr Opin Chem Biol 3:363-368.
18. Bayliss MK, Frick LW. 1999. High-throughput pharmacokinetics: Cassette dosing. Curr Opin Drug Discovery Devel 2:20-25.
19. Kariv I, Cao H, Oldenburg KR. 2001. Development of a high throughput equilibrium dialysis method. J Pharm Sci 90:580-587.
20. Tarbit MH, Berman J. 1998. High throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds. Curr Opin Chem Biol 2:401-406.
21. Schultz P, Dick P, Blaschke TF, Hollister I. 1985. Discrepancies between pharmacokinetic studies of amitriptyline. Clin Pharmacokinet 10:257-258.
22. Gustavson LE, Benet LZ. 1985. Pharmacokinetics of natural and synthetic glucocorticoids. In: Butterworth's International Medical Reviews in Endocrinology. Vol. 4, The Adrenal Cortex. Anderson DC, Winter JSD, editors. London: Butterworth & Company, pp. 234-271.
23. Greenblatt DJ, Allen MD, Harmatz JS, Shader RI. 1980. Diazepam disposition determinants. Clin Pharmacol Ther 26:291-302.
24. Sallee FR, Pollock BG. 1990. Clinical pharmacokinetics of imipramine and desipramine. Clin Pharmacokinet 18:335-354.
25. White PF, Way WL, Trevor A. 1982. Ketamine, pharmacology and therapeutic use. Anesthesiology 56:119-135.
26. Nattel S, Gagne G, Pineau M. 1987. The pharmacokinetics of lignocaine and β-adrenoceptor antagonists in patients with acute myocardial infarction. Clin Pharmacokinet 13:283-306.
27. Colangelo PM, Blouin RA, Steinmetz JE, McNamara PJ, DeMaria AN, Wedlund PJ. 1992. Age and propranolol stereoselective disposition in humans. Clin Pharmacol Ther 51:489-494.
28. Hutabarat RM, Unadkat JD, Sahajwalla C, McNamara S, Ramsey B, Smith AI. 1991. Disposition of drugs in cystic fibrosis. I. Sulfamethoxazole and trimethoprim. Clin Pharmacol Ther 49:392-399.
29. Balant L. 1981. Clinical pharmacokinetics of sulphonylurea hypoglycemic drugs. Clin Pharmacokinet 6:215-240.
30. Chan E, McLachlan AJ, Pegg M, MacKay AD, Cole RB, Rowland M. 1994. Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin. Br J Clin Pharmacol 36:563-569.
31. Jusko WJ, Gretch M. 1976. Plasma and tissue protein binding of drugs in pharmacokinetics. Drug Metab Rev 5(1):42-139.
32. Wallace WM, Verbeek RK. 1987. Plasma protein binding of drugs in the elderly. Clin Pharmacokinet 12:40-72.
33. Zini R, Riant P, Barre J, Tillement JP. 1990. Disease-induced variations in plasma protein levels. Clin Pharmacokinet 19(2):147-159.
34. Routledge PA, Barchowsky A, Bjornsson A, Kitchell BB, Shand DG. 1980. Lidocaine plasma protein binding. Clin Pharmacol Ther 26(3):336-347.
35. Lima JJ, MacKichan JJ, Libertin N, Sabino J. 1983. Influence of volume shifts on drug binding during equilbrium dialysis: correction and attenuation. J Pharmacokinet Biopharm 11:483-498.
36. Khor SP, Wu HJ, Boxenbaum H. 1985. Simultaneous correction for volume shifts and leakage in equilibrium dialysis protein binding experiments. Int J Pharm 23:109-113.